Literature DB >> 2823256

Subpopulations of MCF7 cells separated by Percoll gradient centrifugation: a model to analyze the heterogeneity of human breast cancer.

M Resnicoff1, E E Medrano, O L Podhajcer, A I Bravo, L Bover, J Mordoh.   

Abstract

Exponentially growing MCF7 human breast cancer cells were separated in Percoll gradients into six different fractions of increasing density (A to F). These fractions could be subcultured and were found to contain different cellular subpopulations as defined by the following criteria: ability to generate other cellular subpopulations; growth rate; DNA synthesis; and expression of estrogen receptors, ras oncogene-encoded protein p21, and carcinoembryonic antigen. One of the minor fractions (E), which contained about 5% of the total cell number, appeared to contain the stem cells, on the basis of the following criteria: (i) its ability to reproduce the other cellular subpopulations, (ii) its high rate of growth and DNA synthesis, and (iii) the inability of the other subpopulations to generate it. The most differentiated subpopulation appeared to be the densest one (F), since it was the slowest growing and appeared to be the end point of the other subpopulations.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2823256      PMCID: PMC299279          DOI: 10.1073/pnas.84.20.7295

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  12 in total

1.  Expression of the 21,000 molecular weight ras protein in a spectrum of benign and malignant human mammary tissues.

Authors:  N Ohuchi; A Thor; D L Page; P H Hand; S A Halter; J Schlom
Journal:  Cancer Res       Date:  1986-05       Impact factor: 12.701

2.  A human cell line from a pleural effusion derived from a breast carcinoma.

Authors:  H D Soule; J Vazguez; A Long; S Albert; M Brennan
Journal:  J Natl Cancer Inst       Date:  1973-11       Impact factor: 13.506

Review 3.  Perspectives on clonogenic tumor cells, stem cells, and oncogenes.

Authors:  R N Buick; M N Pollak
Journal:  Cancer Res       Date:  1984-11       Impact factor: 12.701

4.  Expression of murine mammary tumor virus-related antigens in human breast carcinoma (MCF-7) cells.

Authors:  N S Yang; H D Soule; C M McGrath
Journal:  J Natl Cancer Inst       Date:  1977-11       Impact factor: 13.506

Review 5.  Clonogenic and nonclonogenic in vitro chemosensitivity assays.

Authors:  L M Weisenthal; M E Lippman
Journal:  Cancer Treat Rep       Date:  1985-06

6.  Monoclonal antibodies to the p21 products of the transforming gene of Harvey murine sarcoma virus and of the cellular ras gene family.

Authors:  M E Furth; L J Davis; B Fleurdelys; E M Scolnick
Journal:  J Virol       Date:  1982-07       Impact factor: 5.103

7.  Varying degrees of amplification of the N-ras oncogene in the human breast cancer cell line MCF-7.

Authors:  K A Graham; C L Richardson; M D Minden; J M Trent; R N Buick
Journal:  Cancer Res       Date:  1985-05       Impact factor: 12.701

8.  Direct mutagenesis of Ha-ras-1 oncogenes by N-nitroso-N-methylurea during initiation of mammary carcinogenesis in rats.

Authors:  H Zarbl; S Sukumar; A V Arthur; D Martin-Zanca; M Barbacid
Journal:  Nature       Date:  1985 May 30-Jun 5       Impact factor: 49.962

9.  Relation of in vitro properties to tumorigenicity for a series of sublines of the human breast cancer cell line MCF-7.

Authors:  W B Butler; P J Berlinski; R M Hillman; W H Kelsey; M M Toenniges
Journal:  Cancer Res       Date:  1986-12       Impact factor: 12.701

10.  Primary bioassay of human tumor stem cells.

Authors:  A W Hamburger; S E Salmon
Journal:  Science       Date:  1977-07-29       Impact factor: 47.728

View more
  25 in total

1.  Sacrificial Bioprinting of a Mammary Ductal Carcinoma Model.

Authors:  Margaux Duchamp; Tingting Liu; Anne M van Genderen; Vanessa Kappings; Rahmi Oklu; Leif W Ellisen; Yu Shrike Zhang
Journal:  Biotechnol J       Date:  2019-05-27       Impact factor: 4.677

2.  CHIP buffers heterogeneous Bcl-2 expression levels to prevent augmentation of anticancer drug-resistant cell population.

Authors:  M Tsuchiya; Y Nakajima; T Waku; H Hiyoshi; T Morishita; R Furumai; Y Hayashi; H Kishimoto; K Kimura; J Yanagisawa
Journal:  Oncogene       Date:  2014-12-01       Impact factor: 9.867

3.  KT5823 differentially modulates sodium iodide symporter expression, activity, and glycosylation between thyroid and breast cancer cells.

Authors:  Sasha Beyer; Aparna Lakshmanan; Yu-Yu Liu; Xiaoli Zhang; Irene Wapnir; Albert Smolenski; Sissy Jhiang
Journal:  Endocrinology       Date:  2011-01-05       Impact factor: 4.736

4.  Aluminum phthalocyanine tetrasulfonate in MCF-10F, human breast epithelial cells: a hole burning study.

Authors:  N Milanovich; T Reinot; J M Hayes; G J Small
Journal:  Biophys J       Date:  1998-05       Impact factor: 4.033

5.  A 23-pS Ca2(+)-activated K+ channel in MCF-7 human breast carcinoma cells: an apparent correlation of channel incidence with the rate of cell proliferation.

Authors:  E A Wegman; J A Young; D I Cook
Journal:  Pflugers Arch       Date:  1991-02       Impact factor: 3.657

6.  High-throughput ectopic expression screen for tamoxifen resistance identifies an atypical kinase that blocks autophagy.

Authors:  Laura Gonzalez-Malerva; Jaehong Park; Lihua Zou; Yanhui Hu; Zahra Moradpour; Joseph Pearlberg; Jacqueline Sawyer; Hallam Stevens; Ed Harlow; Joshua LaBaer
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-13       Impact factor: 11.205

7.  Identification and characterization of different subpopulations in a human lung adenocarcinoma cell line (A549).

Authors:  M V Croce; A G Colussi; M R Price; A Segal-Eiras
Journal:  Pathol Oncol Res       Date:  1999       Impact factor: 3.201

8.  Loss of the tumor suppressor spinophilin (PPP1R9B) increases the cancer stem cell population in breast tumors.

Authors:  I Ferrer; E M Verdugo-Sivianes; M A Castilla; R Melendez; J J Marin; S Muñoz-Galvan; J L Lopez-Guerra; B Vieites; M J Ortiz-Gordillo; J M De León; J M Praena-Fernandez; M Perez; J Palacios; A Carnero
Journal:  Oncogene       Date:  2015-09-21       Impact factor: 9.867

9.  Antiestrogen-resistant subclones of MCF-7 human breast cancer cells are derived from a common monoclonal drug-resistant progenitor.

Authors:  Kathryn R Coser; Ben S Wittner; Noël F Rosenthal; Sabrina C Collins; Antonia Melas; Shannon L Smith; Crystal J Mahoney; Keiko Shioda; Kurt J Isselbacher; Sridhar Ramaswamy; Toshi Shioda
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-25       Impact factor: 11.205

10.  Cell cycle synchronization induced by tamoxifen and 17 beta-estradiol on MCF-7 cells using flow cytometry and a monoclonal antibody against bromodeoxyuridine.

Authors:  S Bruno; A Di Vinci; E Geido; W Giaretti
Journal:  Breast Cancer Res Treat       Date:  1988-07       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.